PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression

Journal of Affective Disorders

Volumn 82, Issue 2, 2004, Pages 321-327

  Reivich, Martin ^a   Amsterdam, Jay D ^a   Brunswick, David J ^a   Yann Shiue, Chyng ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

11C (+)McN5652; Binding potential; Major depression; Neurotransmitters; PET; Serotonin transporter

Indexed keywords

1,2,3,5,6,10B HEXAHYDRO 6 (4 METHYLTHIOPHENYL)PYRROLO[2,1 A]ISOQUINOLINE C 11; LIGAND; RADIOPHARMACEUTICAL AGENT; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; CONTROLLED STUDY; DISTRIBUTION VOLUME; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR DEPRESSION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEX DIFFERENCE;

ADULT; BRAIN; CARBON RADIOISOTOPES; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOQUINOLINES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; POSITRON-EMISSION TOMOGRAPHY; REFERENCE VALUES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 5644251962     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2003.12.014     Document Type: Article

References (45)

1. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133
2. Barker E.L., Blakely R.D. Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;Raven, New York
3. Baxter L.R. Jr., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry. 46:1989;243-250
4. Bench C.J., Friston K.J., Brown R.G., Frackowiak R.S., Dolan R.J. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol. Med. 23:1993;579-590
5. Benmansour S., Owens W.A., Cecchi M., Morilak D.A., Frazer A. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J. Neurosci. 22:2002;6766-6772
6. Biver F., Wikler D., Lotstra F., Damhaut P., Goldman S., Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br. J. Psychiatry. 171:1997;444-448
7. Bremner J.D., Innis R.B., Salomon R.M., Staib L.H., Ng C.K., Miller H.L., et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch. Gen. Psychiatry. 54:1997;364-374
8. 99mTc]TRODAT-1 SPECT imaging. Am. J. Psychiatry. 160:2003;1836-1841
9. Buchert R., Thomasius R., Nebeling B., Petersen K., Obrocki J., Jenicke L., et al. Long-term effects of "Ecstasy" use on serotonin transporters of the brain investigated by PET. J. Nucl. Med. 44:2003;375-384
10. Dannals R.F., Ravert H.T., Wilson A.A., Scheffel U., Frost J.J., Wagner H.N. Jr. Synthesis of a radiotracer for studying serotonin uptake sites: carbon-11 labeled N-methyl-paroxetine. J. Lab. Comp. Radiopharm. 26:1989;205-206
11. 11C]citalopram. Appl. Radiat. Isot. 41:1990;541
12. D'haenen H., Bossuyt A., Mertens J., Bossuyt-Piron C., Gijsemans M., Kaufman L. SPECT imaging of serotonin2 receptors in depression. Psychiatry Res. Neuroimaging. 45:1992;227-237
13. Dolan R.J., Bench C.J., Brown R.G., Scott L.C., Frackowiak R.S. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow. Psychol. Med. 24:1994;849-857
14. Drevets W.C., Price J.L., Simpson J.R. Jr., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal abnormalities in mood disorders. Nature. 386:1997;824-827
15. 3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression. J. Neurochem. 56:1991;1581-1586
16. 11C]β-CIT binding to monoamine transporters in the monkey and the human brain. Synapse. 16:1994;93-103
17. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for Axis I DSM-IV Disorders - Patient Edition. 1994;American Psychiatric Press, Washington, DC
18. George M.S., Ketter T.A., Parekh P.I., Horwitz B., Herscovitch P., Post R.M. Brain activity during transient sadness and happiness in healthy women. Am. J. Psychiatry. 152:1995;341-351
19. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62
20. Hiltunen J., Akerman K.K., Kuikka J.T., Bergstrom K.A., Halldin C., Nikula T., et al. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Eur. J. Nucl. Med. 25:1998;19-23
21. 11C](+)McN5652. Biol. Psychiatry. 51:2002;715-722
22. Karp J.S., Freifelder R., Geagan M.J., Muehllehner G., Kinahan P.E., Lewitt R.M., Shao L. 3D imaging characteristics of the HEAD PENN-PET scanner. J. Nucl. Med. 38:1997;636-643
23. 11C]Raclopride studies. J. Cereb. Blood Flow Metab. 16:1996;42-52
24. Larisch R., Meyer W., Klimke A., Kehren F., Vosberg H., Muller-Gartner H.W. Left-right asymmetry of striatal dopamine D-2 receptors. Nucl. Med. Commun. 19:1998;781-787
25. 123I]b-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse. 13:1993;295-309
26. 3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls. J. Psychiatry Neurosci. 22:1997;185-191
27. Leake A., Fairbairn A.F., McKeith I.G., Ferrier I.N. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates. Psychiatry Res. 39:1991;155-165
28. 123I]-2-β-carbomethoxy-3-β-(4- iodophenyl)tropane and single photon emission computed tomography. Biol. Psychiatry. 44:1998;1090-1098
29. Mann J.J., Arango V., Marzuk P.M., Theccanat S., Reis D.J. Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies. Br. J. Psychiatry. 155:1989;S7
30. Meltzer C.C., Price J.C., Mathis C.A., Greer P.J., Cantwell M.N., Houck J.R., et al. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am. J. Psychiatry. 156:1999;1871-1878
31. 123I]- 2-β-carbomethoxy-3-β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol. Psychiatry. 47:2000;158-160
32. Neumeyer J.L., Tamangnan G., Wang S., Gao Y., Milius R.A., Kula M.S., Baldessarini R.J. N-substituted analogs of 2-β-carbomethoxy-3-β- (4′-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J. Med. Chem. 39:1996;543-548
33. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40:1994;288-295
34. 11C]McN 5652. J. Nucl. Med. 41:2000;1465-1477
35. Pirker W., Asenbaum S., Kasper S., Walter H., Angelberger P., Koch G., et al. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J. Neural Transm. 100:1995;247-256
36. 11C-fluoxetine as in vivo ligands for the serotonin uptake site. J. Nucl. Med. 31:1990;883
37. Scheffel U., Dannals R.F., Suehiro M., Ricaurte G.A., Carroll F.I., Kuhar M.J., Wagner H.N. Jr. Development of PET/SPECT ligands for the serotonin transporter. Sorer H., Rapaka R.S. NIDA Research Monograph 138: Imaging Techniques in Medications Development. 1994;111-130
38. Shank R.P., Vaught J.L., Pelley K.A., Setler P.E., McComsey D.F., Maryanoff B.E. McN-5652: a highly potent inhibitor of serotonin uptake. J. Pharm. Exp. Ther. 247:1988;1032-1038
39. Smith K.A., Morris J.S., Friston K.J., Cowen P.J., Dolan R.J. Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br. J. Psychiatry. 174:1999;525-529
40. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J. Psychiatr. Res. 31:1997;393-432
41. 11C](+)McN5652-Z. J. Lab. Comp. Radiopharm. 31:1992;841-848
42. 11C]DDPI). Nucl. Med. Biol. 19:1992;549
43. Suehiro M., Scheffel U., Dannals R.F., Ravert H.T., Ricaurte G.A., Wagner H.N. Jr. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. J. Nucl. Med. 34:1993;120-127
44. 123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol. Psychiatry. 47:2000;482-489
45. 3H]cyanoimipramine. J. Pharmacol. Exp. Ther. 241:1987;196-203